Benzinga | Aug 24, 2021 05:40AM EDT

Piper Sandler Initiates Coverage On Omega Therapeutics with Overweight Rating, Announces Price Target of $30

Piper Sandler analyst Edward Tenthoff initiates coverage on Omega Therapeutics (NASDAQ:OMGA) with a Overweight rating and announces Price Target of $30.